Ethyl-5-((1H-pyrrol-2-yl)methylene)-4-oxo-2-(p-tolylamino)-4,5-dihydrothiophene-3-carboxylate

ID: ALA5202193

PubChem CID: 137124420

Max Phase: Preclinical

Molecular Formula: C19H18N2O3S

Molecular Weight: 354.43

Names and Identifiers

Canonical SMILES:  CCOC(=O)C1=C(Nc2ccc(C)cc2)S/C(=C\c2ccc[nH]2)C1=O

Standard InChI:  InChI=1S/C19H18N2O3S/c1-3-24-19(23)16-17(22)15(11-14-5-4-10-20-14)25-18(16)21-13-8-6-12(2)7-9-13/h4-11,20-21H,3H2,1-2H3/b15-11-

Standard InChI Key:  XGMVPTLLTZMLFD-PTNGSMBKSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -0.1195   -0.2493    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7870    0.2354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5321    1.0201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2929    1.0201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5478    0.2354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3446    0.0219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5581   -0.7747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3549   -0.9885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5670   -1.7831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9835   -2.3666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1903   -2.1557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9723   -1.3605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7053    1.7345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2929    2.4489    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7053    3.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5302    3.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5302    1.7345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9445    1.7345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5837    0.0219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7972   -0.7747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2784   -1.4154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7275   -2.1070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5238   -1.8936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5670   -1.0702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1970   -3.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  5  6  1  0
  6  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
 11 10  1  0
 12 11  2  0
  7 12  1  0
  4 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  2  0
  3 18  2  0
  2 19  2  0
 19 20  1  0
 21 20  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 20  1  0
 10 25  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5202193

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 354.43

Molecular Weight (Monoisotopic): 354.1038

AlogP: 3.87

#Rotatable Bonds: 5

Polar Surface Area: 71.19

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.13

CX Basic pKa: ┄

CX LogP: 4.24

CX LogD: 4.24

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.48

Np Likeness Score: -1.13

References

1. Hwang J, Qiu X, Borgelt L, Haacke N, Kanis L, Petroulia S, Gasper R, Schiller D, Lampe P, Sievers S, Imig J, Wu P..  (2022)  Synthesis and evaluation of RNase L-binding 2-aminothiophenes as anticancer agents.,  58  [PMID:35152173] [10.1016/j.bmc.2022.116653]

Source

Source(1):

• Scientific Literature